EXEMPA LIN MET XR 10/5/1000MG TAB

EXEMPA LIN MET XR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 10mg, Linagliptin 5mg, and Metformin HCL 1000mg—three proven antidiabetic agents working synergistically to improve glycemic control. Empagliflozin helps reduce blood glucose by promoting urinary glucose excretion, while Linagliptin enhances insulin secretion through DPP-4 inhibition. Metformin improves insulin sensitivity and reduces hepatic glucose production. This combination addresses multiple pathways of hyperglycemia, making it suitable for patients requiring intensified diabetes therapy. The extended-release formulation ensures sustained medication delivery throughout the day, supporting consistent blood sugar management with convenient once-daily dosing. Ideal for Type 2 diabetes patients inadequately controlled on monotherapy or dual therapy. Always use as directed by your healthcare provider.